Last reviewed · How we verify

NCT03747445

Microstructural Analysis of Ingestive Behavior After Roux-en-Y Gastric Bypass - Pilot

Completed Last updated 11 June 2021
What this trial tests

trial testing Roux-en-Y gastric bypass in Meal in 30 participants. Completed in 30 September 2020.

Timeline
1 February 2018
Primary endpoint
30 June 2018
30 September 2020

Quick facts

Lead sponsorMarco Bueter
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 February 2018
Primary completion30 June 2018
Estimated completion30 September 2020
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Marco Bueter

Who can join

Adults 18 to 65, female only, with Meal or Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ability to assess ingestion in fine detail over the time course of a liquid meal allows for comparison of early and late meal features of drinking and may help dissociate manipulations (surgical, neural, pharmacological, etc.) that affect orosensory properties from those that are modulating postoral processes in the control of intake. The aim of the study is to asses microstructural changes in liquid meal intake over 1-year in severely obese patients after Roux-en-Y gastric bypass (RYGB).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Microstructural changes in human ingestive behavior after Roux-en-Y gastric bypass during liquid meals.
    Gero D, File B, Alceste D, Frick LD, et al · · 2021 · cited 12× · PMID 34369388 · DOI 10.1172/jci.insight.136842

Verify or expand the search:

Other trials of Roux-en-Y gastric bypass

Trials testing the same drug.

Other Marco Bueter trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing